14-64779238-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001355436.2(SPTB):​c.4482G>A​(p.Val1494Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.26 in 1,604,858 control chromosomes in the GnomAD database, including 61,948 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 11186 hom., cov: 32)
Exomes 𝑓: 0.25 ( 50762 hom. )

Consequence

SPTB
NM_001355436.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.432

Publications

18 publications found
Variant links:
Genes affected
SPTB (HGNC:11274): (spectrin beta, erythrocytic) This locus encodes a member of the spectrin gene family. Spectrin proteins, along with ankyrin, play a role in cell membrane organization and stability. The protein encoded by this locus functions in stability of erythrocyte membranes, and mutations in this gene have been associated with spherocytosis type 2, hereditary elliptocytosis, and neonatal hemolytic anemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
SPTB Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • elliptocytosis 3
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary elliptocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.29).
BP6
Variant 14-64779238-C-T is Benign according to our data. Variant chr14-64779238-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 257119.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.432 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.607 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPTBNM_001355436.2 linkc.4482G>A p.Val1494Val synonymous_variant Exon 22 of 36 ENST00000644917.1 NP_001342365.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPTBENST00000644917.1 linkc.4482G>A p.Val1494Val synonymous_variant Exon 22 of 36 NM_001355436.2 ENSP00000495909.1
SPTBENST00000553938.5 linkc.477G>A p.Val159Val synonymous_variant Exon 3 of 18 1 ENSP00000451324.1
SPTBENST00000389722.7 linkc.4482G>A p.Val1494Val synonymous_variant Exon 21 of 35 2 ENSP00000374372.3
SPTBENST00000389720.4 linkc.4482G>A p.Val1494Val synonymous_variant Exon 22 of 32 5 ENSP00000374370.4

Frequencies

GnomAD3 genomes
AF:
0.341
AC:
51788
AN:
151730
Hom.:
11159
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.612
Gnomad AMI
AF:
0.244
Gnomad AMR
AF:
0.209
Gnomad ASJ
AF:
0.262
Gnomad EAS
AF:
0.338
Gnomad SAS
AF:
0.381
Gnomad FIN
AF:
0.228
Gnomad MID
AF:
0.310
Gnomad NFE
AF:
0.228
Gnomad OTH
AF:
0.325
GnomAD2 exomes
AF:
0.267
AC:
66453
AN:
248638
AF XY:
0.269
show subpopulations
Gnomad AFR exome
AF:
0.619
Gnomad AMR exome
AF:
0.136
Gnomad ASJ exome
AF:
0.260
Gnomad EAS exome
AF:
0.329
Gnomad FIN exome
AF:
0.224
Gnomad NFE exome
AF:
0.228
Gnomad OTH exome
AF:
0.262
GnomAD4 exome
AF:
0.251
AC:
364781
AN:
1453010
Hom.:
50762
Cov.:
32
AF XY:
0.254
AC XY:
183546
AN XY:
722990
show subpopulations
African (AFR)
AF:
0.633
AC:
21047
AN:
33234
American (AMR)
AF:
0.145
AC:
6476
AN:
44632
Ashkenazi Jewish (ASJ)
AF:
0.267
AC:
6942
AN:
26012
East Asian (EAS)
AF:
0.322
AC:
12709
AN:
39522
South Asian (SAS)
AF:
0.366
AC:
31383
AN:
85748
European-Finnish (FIN)
AF:
0.220
AC:
11701
AN:
53210
Middle Eastern (MID)
AF:
0.299
AC:
1716
AN:
5746
European-Non Finnish (NFE)
AF:
0.232
AC:
255833
AN:
1104810
Other (OTH)
AF:
0.282
AC:
16974
AN:
60096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.404
Heterozygous variant carriers
0
13544
27089
40633
54178
67722
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9000
18000
27000
36000
45000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.341
AC:
51853
AN:
151848
Hom.:
11186
Cov.:
32
AF XY:
0.339
AC XY:
25198
AN XY:
74232
show subpopulations
African (AFR)
AF:
0.613
AC:
25322
AN:
41320
American (AMR)
AF:
0.209
AC:
3185
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.262
AC:
908
AN:
3472
East Asian (EAS)
AF:
0.337
AC:
1737
AN:
5152
South Asian (SAS)
AF:
0.380
AC:
1831
AN:
4816
European-Finnish (FIN)
AF:
0.228
AC:
2406
AN:
10572
Middle Eastern (MID)
AF:
0.323
AC:
95
AN:
294
European-Non Finnish (NFE)
AF:
0.228
AC:
15471
AN:
67934
Other (OTH)
AF:
0.321
AC:
676
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1516
3032
4548
6064
7580
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
486
972
1458
1944
2430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.274
Hom.:
20404
Bravo
AF:
0.350
Asia WGS
AF:
0.370
AC:
1287
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 26, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Elliptocytosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spherocytosis type 2 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Spherocytosis, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.29
CADD
Benign
11
DANN
Benign
0.75
PhyloP100
-0.43
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1741488; hg19: chr14-65245956; COSMIC: COSV67631360; API